Shawn Cross's Net Worth
$398 Thousand
Who is Shawn Cross?
Shawn Cross does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Applied Molecular Transport Inc., BioPlus Acquisition Corp., GT Biopharma, Inc., and Cyclo Therapeutics, Inc..
SEC CIK
Shawn Cross's CIK is 0001734779
Past Insider Trading and Trends
2021 was Shawn Cross's most active year for acquiring shares with 4 total transactions. Shawn Cross's most active month to acquire stocks was the month of July. 2023 was Shawn Cross's most active year for disposing of shares, totalling 14 transactions. Shawn Cross's most active month to dispose stocks was the month of November. 2021 saw Shawn Cross paying a total of $46,100.00 for 104,500 shares, this is the most they've acquired in one year. In 2021 Shawn Cross cashed out on 20,000 shares for a total of $301,193.19, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Applied Molecular Transport Inc. (AMTI) No price found
CEO & Chair the Board
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -545.50K |
—
|
—
|
0
|
Dec 27
| |||
Form 4
| -16.88% | -110.80K |
$0.16 | -$18,116.13 | 545.5K |
Nov 22
| |||
Form 4
| -12.11% | -90.45K |
$0.16 | -$14,525.79 | 656.3K |
Nov 15
| |||
Form 4
| -0.74% | -5.56K |
$0.23 | -$1,297.70 | 746.75K |
Jun 2 - Sep 5
| |||
Form 4
| +1,150.59% | 692.15K |
$0.16 | -$30,742.66 | 752.31K |
Sep 28 - Sep 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 24
| |||
Form 4
| -1.53% | -934.00 |
$0.50 | -$467.00 | 60.16K |
Mar 1
| |||
Form 4
| -5.99% | -3.89K |
$1.05 | -$4,088.04 | 61.09K |
Dec 2
| |||
Form 4
| -1.34% | -884.00 |
$1.42 | -$1,255.38 | 64.98K |
Sep 1
| |||
Form 4
| -2.85% | -3.93K |
$3.01 | -$11,834.33 | 133.85K |
Jun 1 - Jun 2
| |||
Form 4
| +34.78% | 18K |
—
|
—
| 69.75K |
May 16
| |||
Form 4
| +64.29% | 20.25K |
—
|
—
| 51.75K |
Feb 15
| |||
Form 4
|
∞
| 31.5K |
—
|
—
| 31.5K |
Dec 24
| |||
Form 4
|
—
|
0
|
$17.37 | -$255,093.19 |
0
|
Scheduled
|
Aug 19 - Aug 23
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BioPlus Acquisition Corp. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
GT Biopharma, Inc. (GTBP) Snapshot price: $2.1
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Cyclo Therapeutics, Inc. (CYTH) Snapshot price: $0.6693
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +11.08% | 9.03K |
—
|
—
| 90.52K |
Aug 16
| |||
Form 4
| +12.24% | 8.89K |
—
|
—
| 81.49K |
Jun 3
| |||
Form 4
|
∞
| 72.61K |
—
|
—
| 72.61K |
Dec 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Pacira BioSciences, Inc. (PCRX) No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 75K |
—
|
—
| 75K |
Nov 1 - Nov 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||